Beacon was established in 2016 by a skilled team in pharmaceutical discovery harnessing modern developments in the field of G-Protein Coupled Receptors (GPCRs). Our team consists of committed researchers who have collaborated for over fifteen years and are globally renowned in all aspects of GPCR-focused drug discovery. Serving as a GPCR drug discovery hub, Beacon has utilized its research portfolio and knowledge to form partnerships with both emerging biotech companies and major pharmaceutical partners, validating our approach. We believe that Beacon possesses unparalleled experience and expertise in this field.